Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹752 Cr₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of GLAND PHARMA is ₹752 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹752 Cr
Mar2025₹2,186 Cr
Mar2024₹-1,560 Cr
Mar2023₹1,587 Cr
Mar2022₹-177 Cr

How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹752 Cr
-65.59
Mar2025 ₹2,186 Cr
Positive
Mar2024 ₹-1,560 Cr
Negative
Mar2023 ₹1,587 Cr
Positive
Mar2022 ₹-177 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹54,302.3 Cr -1.3% 12.5% 76.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.3%

12.5%

76.4%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses